RDHL
RedHill Biopharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.72
+1.63%Margins
Gross margin
64.5%
EBITDA margin
-82.8%
EBIT margin
-110.4%
Net margin
-97.5%
FCF margin
-86.0%
211.1%
Return on equity
-50.7%
Return on assets
251.1%
Return on invested capital
0.52x
Asset turnover
-$8.2M
Cash from operations
$0.47
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025